Hottest Stories: Ralph Lauren Corporation (NYSE:RL), Apollo Investment Corporation (NASDAQ:AINV), Albany Molecular Research (NASDAQ:AMRI), Sangamo Biosciences (NASDAQ:SGMO)

Posted by on Jan 15, 2016

Citrix Systems, Inc. (NASDAQ:CTXS) shares increased 0.16% in last trading session and ended the day at $67.38. CTXS Gross Margin is 81.80% and its has a return on assets of 5.20%. Citrix Systems, Inc. (NASDAQ:CTXS) quarterly performance is -8.40%.

Citrix Systems, Inc. (NASDAQ:CTXS), announced that it plans to report financial results for the fourth quarter ended December 31, 2015 on Wednesday, January 27, 2016 after market close. A news release will be issued at approximately 4:05 p.m

Ralph Lauren Corporation (NYSE:RL) ended the last trading day at $101.04. Company weekly volatility is calculated as 4.19% and price to cash ratio as 7.60. Ralph Lauren Corporation (NYSE:RL) showed a weekly performance of -3.37%.

Ralph Lauren Corporation (NYSE:RL) will release its Third Quarter Fiscal Year 2016 results for the period ended December 26, 2015 at approximately 8:00 A.M. Eastern, Thursday, February 4, 2016. At 9:00 A.M. Eastern, on the same day, the Company will host a conference call for analysts, investors and other interested parties.

On 14 January, Apollo Investment Corporation (NASDAQ:AINV) shares advanced 1.20% and was closed at $5.04. AINV EPS growth in last 5 year was -27.10%. Apollo Investment Corporation (NASDAQ:AINV) year to date (YTD) performance is -3.45%.

Apollo Investment Corporation (NASDAQ:AINV) announced that it will report its third quarter results for the period ended December 31, 2015 prior to the opening of the financial markets on Tuesday, February 9, 2016.

Albany Molecular Research Inc. (NASDAQ:AMRI) shares advanced 1.46% in last trading session and ended the day at $17.43. AMRI Gross Margin is 25.50% and its has a return on assets of -1.00%. Albany Molecular Research Inc. (NASDAQ:AMRI) quarterly performance is 1.22%.

Albany Molecular Research Inc. (NASDAQ:AMRI) is pleased to announce the extension of a key insourcing relationship with a major pharmaceutical company designed to accelerate their chemistry and drug discovery efforts. The original insourcing collaboration, which commenced in 2011, is being extended significantly beyond its original termination date of December 2018 to December 31, 2021.

Sangamo Biosciences Inc. (NASDAQ:SGMO) caters to the Healthcare space. It has a net profit margin of -68.10% and weekly performance is -16.73%. On the last day of trading company shares ended up at $6.37. Sangamo Biosciences Inc. (NASDAQ:SGMO) distance from 50-day simple moving average (SMA50) is -46.52%.

Sangamo BioSciences, Inc. (NASDAQ:SGMO), presented an overview of the Company’s therapeutic programs and business strategy at 9:30 am PT, on Tuesday, January 12, 2016, at the 34th Annual J.P. Morgan Healthcare Conference.

Leave a Reply

Your email address will not be published. Required fields are marked *